MOTS-c: Exploring the Research Behind a Mitochondrial-Derived Peptide

What Is MOTS-c?

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a naturally occurring research peptide that is unusual in one important respect: it is encoded by the mitochondrial genome rather than by nuclear DNA. It is a small, 16-amino-acid mitochondrial-derived peptide (MDP) translated from a short open reading frame nested within the mitochondrial 12S rRNA gene. First described in 2015, MOTS-c belongs to an emerging class of signaling molecules sometimes called "mitokines" — peptides that appear to allow mitochondria to communicate with the rest of the cell and body. This makes MOTS-c a compelling subject in preclinical studies exploring metabolic homeostasis, cellular energy sensing, and mitochondrial-to-nuclear signaling.

Unlike peptides synthesized from nuclear genes, MOTS-c is translated in the cytoplasm and is found both inside mitochondria and in circulation, where its levels have been observed to decline with age in research models. Because of this, it has drawn particular interest in studies of metabolic aging and age-related physiological decline.

The Discovery of Mitochondrial-Derived Peptides

For much of modern biology, the mitochondrial genome was thought to encode only a small set of proteins involved directly in energy production. The identification of humanin — a peptide encoded within mitochondrial DNA — challenged that view and suggested that additional short open reading frames (sORFs) might be hidden within the mitochondrial genome. MOTS-c was identified as one such peptide, encoded within the 12S rRNA region.

What made MOTS-c especially notable in subsequent research was the observation that it does not act only within the cytoplasm. Laboratory findings indicate that, under certain conditions, MOTS-c can move into the cell nucleus and influence the expression of nuclear genes — a form of "retrograde" signaling from mitochondria to the nucleus. This positioned MOTS-c as an experimental model for studying how the two genomes of the cell may coordinate with one another.

Mechanism of Interest in Research

In controlled laboratory settings, MOTS-c has been investigated for its influence on several interconnected metabolic pathways:

• AMPK activation — Research indicates MOTS-c may activate AMP-activated protein kinase (AMPK), a central cellular energy sensor, with skeletal muscle appearing to be a primary target tissue
• Folate cycle and purine biosynthesis — Experimental data suggest MOTS-c inhibits the folate one-carbon cycle and its associated de novo purine biosynthesis, leading to accumulation of the metabolite AICAR, which is itself associated with AMPK activation
• Glucose handling — Preclinical findings have linked MOTS-c to increased GLUT4-mediated glucose uptake and improved insulin sensitivity in muscle tissue
• Mitochondrial-to-nuclear signaling — Under metabolic stress such as glucose restriction or oxidative stress, MOTS-c has been observed to translocate to the nucleus in an AMPK-dependent manner and modulate the expression of stress-adaptive genes
• Antioxidant response — Within the nucleus, MOTS-c has been reported to interact with the Nrf2 pathway and genes containing antioxidant response elements (ARE), which are associated with cellular defense against oxidative damage

Together, these observations position MOTS-c as a frequent subject in models exploring metabolism, insulin sensitivity, cellular stress adaptation, and mitochondrial signaling.

Metabolic Research

MOTS-c first drew scientific attention through metabolic studies. In the foundational 2015 work, MOTS-c treatment in mice was reported to help prevent diet-induced obesity and insulin resistance, with effects attributed to activation of AMPK signaling and modulation of the folate–methionine cycle. Skeletal muscle appeared to be the primary tissue involved, consistent with the peptide's proposed role in energy metabolism.

Subsequent experimental work extended these observations to other tissues and models. Studies in cardiac tissue, for example, have investigated whether MOTS-c can influence mitochondrial respiration in the context of metabolic dysfunction, while cell-based studies have examined its effects on glucose uptake and metabolic flexibility. Across these investigations, MOTS-c is frequently described in the research literature as an "exercise mimetic" — a compound that reproduces some of the molecular signatures of physical activity — though this characterization refers strictly to laboratory observations and not to any established human effect.

Exercise, Physical Performance, and Aging Research

One of the most widely discussed lines of MOTS-c research concerns its relationship to exercise and aging. A 2021 study reported that exercise induces endogenous MOTS-c expression in skeletal muscle and circulation in humans, suggesting a natural link between the peptide and physical activity. In parallel mouse experiments, MOTS-c administration was associated with improved physical capacity across young, middle-aged, and old animals.

In these models, older mice treated with MOTS-c showed markedly increased running capacity on treadmill testing compared with untreated animals of the same age, and intermittent late-life treatment was associated with measures of improved healthspan. Researchers also observed shifts in metabolic flexibility, as reflected in the respiratory exchange ratio, suggesting altered fuel utilization. Because circulating MOTS-c levels have been observed to decline with age, these findings have fueled interest in the peptide as a research tool for studying age-related metabolic and physical decline. These outcomes remain experimental and are not indicative of any approved use in humans.

Emerging Areas of Investigation

Beyond metabolism and exercise, MOTS-c has become a subject of interest across several additional research contexts:

• Oxidative stress and tissue protection — Through its association with the Nrf2 antioxidant pathway, MOTS-c has been studied in models of oxidative injury, including experimental work on radiation-induced lung inflammation
• Cardiometabolic function — Studies have examined MOTS-c in the setting of diabetic cardiac tissue and mitochondrial respiration
• Bone and musculoskeletal biology — Some preclinical work has explored MOTS-c in models of bone loss, again linked to AMPK signaling
• Longevity genetics — Population genetic research has examined whether variation within the MOTS-c coding region is associated with exceptional longevity in certain groups

These areas are early and, in many cases, based on animal or cell models. They illustrate the breadth of scientific interest in MOTS-c rather than any confirmed application.

Clinical Translation and Human Data

Human research on MOTS-c remains limited and preliminary. The peptide is detectable in human plasma and, as noted, appears to be induced by exercise, but the large majority of mechanistic and outcome data come from animal and cell-based studies. A MOTS-c-derived analog has entered early-phase human clinical evaluation by a biotechnology developer, representing some of the first human data on this class of compound. At present, no MOTS-c-based product is approved for medical use, and existing findings should be understood as experimental groundwork rather than evidence of clinical benefit.

Research Compound Specifications

Parameter	Specification
Type	Mitochondrial-derived peptide (16-amino-acid)
Derived From	Mitochondrial 12S rRNA gene (short open reading frame)
Research Classification	Mitokine / metabolic peptide
Form	Lyophilized powder
Storage	−20°C, dry and dark environment; avoid repeated freeze-thaw cycles
Application	Research use only — not for human or veterinary use

Laboratory Applications

• Metabolic biology — AMPK pathway signaling studies, glucose uptake assays, and insulin-sensitivity modeling
• Cell biology — Mitochondrial-to-nuclear signaling and subcellular localization studies
• Pharmacology — Mitochondrial peptide characterization and dose-response modeling
• Biochemistry — Peptide stability analysis and enzymatic degradation testing

MOTS-c is supplied strictly as a research compound for laboratory and scientific investigation only. Not approved for human consumption, therapeutic use, clinical application, or diagnostic purposes. All experimentation should be conducted by qualified professionals in appropriate research settings.

References

1. Lee C, Zeng J, Drew BG, et al. The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance. Cell Metabolism. 2015;21(3):443–454. doi:10.1016/j.cmet.2015.02.009
2. Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metabolism. 2018;28(3):516–524.e7. doi:10.1016/j.cmet.2018.06.008
3. Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications. 2021;12(1):470. doi:10.1038/s41467-020-20790-0
4. Lee C, Kim KH, Cohen P. MOTS-c: A Novel Mitochondrial-Derived Peptide Regulating Muscle and Fat Metabolism. Free Radical Biology and Medicine. 2016. doi:10.1016/j.freeradbiomed.2016.05.015
5. Benayoun BA, Lee C. MOTS-c: A Mitochondrial-Encoded Regulator of the Nucleus. BioEssays. 2019;41(9):1900046. doi:10.1002/bies.201900046
6. Zhang Y, Huang J, Zhang Y, et al. The Mitochondrial-Derived Peptide MOTS-c Alleviates Radiation Pneumonitis via an Nrf2-Dependent Mechanism. Antioxidants. 2024;13(5):613. doi:10.3390/antiox13050613
7. Mitochondria-derived peptide MOTS-c restores mitochondrial respiration in the type 2 diabetic heart. Frontiers in Physiology. 2025. doi:10.3389/fphys.2025.1602271
8. Review: Mitochondria-derived peptide MOTS-c — effects and mechanisms related to stress, metabolism, and aging. 2023. PMCID: PMC9854231.
9. Review: MOTS-c — a promising mitochondrial-derived peptide for therapeutic exploitation. 2023. PMCID: PMC9905433.